Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryce B Reeve

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Kidney International Reports|October 26, 2020
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN StudyShannon L Murphy, John D Mahan, Jonathan P Troost, et al.
Cancer|May 16, 2019
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceKirsten A Nyrop, Allison M Deal, Kathryn E Reeder-Hayes, et al.
Cancer|April 22, 2020
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Bryce B Reeve, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 5, 2013
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness researchBryce B Reeve, Kathleen W Wyrwich, Albert W Wu, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2015
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyDavid T Selewski, Jonathan P Troost, Susan F Massengill, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.
Kidney International Reports|October 26, 2020
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN StudyShannon L Murphy, John D Mahan, Jonathan P Troost, et al.
Cancer|May 16, 2019
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practiceKirsten A Nyrop, Allison M Deal, Kathryn E Reeder-Hayes, et al.
Cancer|April 22, 2020
Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancerKirsten A Nyrop, Allison M Deal, Bryce B Reeve, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 5, 2013
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness researchBryce B Reeve, Kathleen W Wyrwich, Albert W Wu, et al.
Health and Quality of Life Outcomes|August 25, 2017
Responsiveness of the PROMIS® measures to changes in disease status among pediatric nephrotic syndrome patients: a Midwest pediatric nephrology consortium studyDavid T Selewski, Jonathan P Troost, Danyelle Cummings, et al.
Pediatric Nephrology (Berlin, Germany)|March 19, 2015
The impact of disease duration on quality of life in children with nephrotic syndrome: a Midwest Pediatric Nephrology Consortium studyDavid T Selewski, Jonathan P Troost, Susan F Massengill, et al.
JCO Oncology Practice|May 12, 2026
Benefits of Electronic Symptom Monitoring During Cancer Treatment by Age, Sex, Race, and Education (Alliance AFT-39)Allison M Deal, Yashasvini Sampathkumar, Brenda F Ginos, et al.
Journal of the National Cancer Institute|October 1, 2014
Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)Ethan Basch, Bryce B Reeve, Sandra A Mitchell, et al.
Pageof 35